References
Feldman AM, et al. N Engl J Med 329: 149–155, 1993
Packer M. N Engl J Med 329: 201–202, 1993
Kubo SH, et al. Cardiovasc Drugs Ther 2: 653–660,1992
Feldman AM, et al. Am J Cardiol 68: 1203–1210, 1991
OPC-8212 Multicenter Research Group. Cardiovasc Drugs Ther 4: 419–426, 1990
Iijima T, Taira N. J Pharmacol Exp Ther 240: 657–662, 1987
Lathrop DA, Schwartz A. Eur J Pharmacol 117: 391–392, 1985
CONSENSUS Trial Study Group. N Engl J Med 316: 1429–1435, 1987
SOLVD Investigators. N Engl J Med 325: 293–302, 1992
Pfeffer MA, et al. N Engl J Med 327: 669–677, 1992
Rapundalo ST, et al. Naun Schmied Arch Pharmacol 338: 692–698, 1988
Anon. Scrip 1774: 24, 1992 † Zolpidem is not available in the UK, The Netherlands, Canada or Australia; zopiclone is not available in Australia or the US
Rights and permissions
About this article
Cite this article
Vesnarinone: First Oral Positive Inotrope to Show Mortality Benefit in Chronic CHF. Drugs Ther. Perspect 2, 7–8 (1993). https://doi.org/10.2165/00042310-199302070-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199302070-00003